@article{ref1,
title="Clinical characterization of brief psychotic disorders triggered by the COVID-19 pandemic: a multicenter observational study",
journal="European archives of psychiatry and clinical neuroscience",
year="2022",
author="Palermo-Zeballos, Fernanda Jazmín and López-Díaz, Álvaro and Ruiz-Ruiz, Elena and Martín-Gil, Victoria Eugenia and Martínez-Molina, Iván and Álvarez-Gil, Paula and Garrido-Torres, Nathalia and Ruiz-Veguilla, Miguel and Crespo-Facorro, Benedicto and Gutiérrez-Rojas, Luis and Prados-Ojeda, Juan Luis and Rosa-Ruiz, Alfonso and Galiano-Rus, Sara and Valdés-Florido, María José and Gómez-Coronado, Rafael and Ruiz-Arcos, Ángela and Guzmán-Del Castillo, Antonio Hipólito and Algarín-Moriana, María Paz and Mota-Molina, Macarena",
volume="272",
number="1",
pages="5-15",
abstract="This study aimed to characterize the clinical profile of patients with brief psychotic disorders (BPD) triggered by the psychosocial distress derived from the COVID-19 crisis. A multicenter study was conducted from March 14 to May 14, 2020 (the peak weeks of the pandemic in Europe). All consecutive patients presenting non-affective psychotic episodes with a duration of untreated psychosis of less than 1 month and whose onset was related to the COVID-19 crisis were recruited, but only those patients meeting Diagnostic Statistical Manual 5th edition (DSM-5) criteria for &quot;BPD with marked stressors&quot; (DSM-5 code: 298.8) during follow-up were finally included. Patients' sociodemographic and clinical characteristics were collected at baseline and summarized with descriptive statistics. During the study period, 57 individuals with short-lived psychotic episodes related to the emotional stress of the COVID-19 pandemic were identified, of whom 33 met DSM-5 criteria for &quot;BPD with marked stressors&quot;. The mean age was 42.33 ± 14.04 years, the gender distribution was almost the same, and the majority were rated as having good premorbid adjustment. About a quarter of the patients exhibited suicidal symptoms and almost half presented first-rank schizophrenia symptoms. None of them were COVID-19 positive, but in more than half of the cases, the topic of their psychotic features was COVID-19-related. The coronavirus pandemic is triggering a significant number of BPD cases. Their risk of suicidal behavior, their high relapse rate, and their low temporal stability make it necessary to closely monitor these patients over time.<p /><p>Language: en</p>",
language="en",
issn="0940-1334",
doi="10.1007/s00406-021-01256-w",
url="http://dx.doi.org/10.1007/s00406-021-01256-w"
}